AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,680,854 | -42.5% | 6,689,789 | 0.0% | 0.90% | -36.2% |
| Q2 2023 | $74,189,760 | -24.3% | 6,689,789 | +4.7% | 1.41% | -30.9% |
| Q1 2023 | $98,043,182 | -21.2% | 6,387,178 | +13.9% | 2.04% | -19.6% |
| Q4 2022 | $124,387,510 | +47.3% | 5,605,566 | +8.4% | 2.54% | +30.4% |
| Q3 2022 | $84,439,000 | +21.2% | 5,170,784 | +7.8% | 1.95% | +8.2% |
| Q2 2022 | $69,671,000 | -21.3% | 4,795,000 | 0.0% | 1.80% | -1.8% |
| Q1 2022 | $88,564,000 | -22.3% | 4,795,000 | 0.0% | 1.83% | +10.2% |
| Q4 2021 | $113,977,000 | -3.5% | 4,795,000 | 0.0% | 1.66% | -6.6% |
| Q3 2021 | $118,101,000 | +19.6% | 4,795,000 | +20.0% | 1.78% | +19.5% |
| Q2 2021 | $98,716,000 | +13.3% | 3,995,000 | 0.0% | 1.49% | +9.6% |
| Q1 2021 | $87,131,000 | -14.5% | 3,995,000 | 0.0% | 1.36% | -20.5% |
| Q4 2020 | $101,952,000 | -7.2% | 3,995,000 | 0.0% | 1.71% | -35.3% |
| Q3 2020 | $109,888,000 | +5.8% | 3,995,000 | 0.0% | 2.65% | -9.4% |
| Q2 2020 | $103,863,000 | – | 3,995,000 | – | 2.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 907,567 | $22,353,000 | 19.68% |
| 5AM Venture Management, LLC | 555,555 | $13,683,000 | 2.78% |
| Octagon Capital Advisors LP | 446,641 | $11,001,000 | 2.71% |
| EcoR1 Capital, LLC | 2,759,505 | $67,967,000 | 2.36% |
| Cormorant Asset Management, LP | 2,162,115 | $53,253,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 126,116 | $3,106,000 | 1.87% |
| RTW INVESTMENTS, LP | 4,795,000 | $118,101,000 | 1.78% |
| Aaron Wealth Advisors LLC | 229,595 | $5,654,000 | 1.59% |
| Altium Capital Management LP | 225,000 | $5,542,000 | 1.45% |
| Boxer Capital, LLC | 1,121,327 | $27,618,000 | 0.96% |